These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
268 related articles for article (PubMed ID: 9853699)
1. Comparison of advanced glycation endproducts on haemoglobin (Hb-AGE) and haemoglobin A1c for the assessment of diabetic control. Turk Z; Mesić R; Benko B Clin Chim Acta; 1998 Oct; 277(2):159-70. PubMed ID: 9853699 [TBL] [Abstract][Full Text] [Related]
2. Long-term assessment of glucose control by haemoglobin-AGE measurement. Wolffenbuttel BH; Giordano D; Founds HW; Bucala R Lancet; 1996 Feb; 347(9000):513-5. PubMed ID: 8596270 [TBL] [Abstract][Full Text] [Related]
3. Assessment of markers of glycaemic control in diabetic patients with chronic kidney disease using continuous glucose monitoring. Vos FE; Schollum JB; Coulter CV; Manning PJ; Duffull SB; Walker RJ Nephrology (Carlton); 2012 Feb; 17(2):182-8. PubMed ID: 21883672 [TBL] [Abstract][Full Text] [Related]
4. Association between serum levels of soluble receptor for advanced glycation end products and circulating advanced glycation end products in type 2 diabetes. Tan KC; Shiu SW; Chow WS; Leng L; Bucala R; Betteridge DJ Diabetologia; 2006 Nov; 49(11):2756-62. PubMed ID: 16969649 [TBL] [Abstract][Full Text] [Related]
5. Serum levels of advanced glycation end products in poorly metabolically controlled children with diabetes mellitus: relation to HbA1c. Jakus V; Bauerová K; Michalková D; Cársky J Diabetes Nutr Metab; 2001 Aug; 14(4):207-11. PubMed ID: 11716290 [TBL] [Abstract][Full Text] [Related]
6. Serum concentrations of advanced glycation endproducts are associated with the development of atherosclerosis as well as diabetic microangiopathy in patients with type 2 diabetes. Aso Y; Inukai T; Tayama K; Takemura Y Acta Diabetol; 2000; 37(2):87-92. PubMed ID: 11194933 [TBL] [Abstract][Full Text] [Related]
7. HbA1c and serum levels of advanced glycation and oxidation protein products in poorly and well controlled children and adolescents with type 1 diabetes mellitus. Kostolanská J; Jakus V; Barák L J Pediatr Endocrinol Metab; 2009 May; 22(5):433-42. PubMed ID: 19618662 [TBL] [Abstract][Full Text] [Related]
8. Increased serum levels of the specific advanced glycation end product methylglyoxal-derived hydroimidazolone are associated with retinopathy in patients with type 2 diabetes mellitus. Fosmark DS; Torjesen PA; Kilhovd BK; Berg TJ; Sandvik L; Hanssen KF; Agardh CD; Agardh E Metabolism; 2006 Feb; 55(2):232-6. PubMed ID: 16423631 [TBL] [Abstract][Full Text] [Related]
9. Serum albumin-adjusted glycated albumin is a better indicator of glycaemic control in diabetic patients with end-stage renal disease not on haemodialysis. Fukami K; Shibata R; Nakayama H; Yamada K; Okuda S; Koga M Ann Clin Biochem; 2015 Jul; 52(Pt 4):488-96. PubMed ID: 25568140 [TBL] [Abstract][Full Text] [Related]
10. Glycated and oxidized protein degradation products are indicators of fasting and postprandial hyperglycemia in diabetes. Ahmed N; Babaei-Jadidi R; Howell SK; Thornalley PJ; Beisswenger PJ Diabetes Care; 2005 Oct; 28(10):2465-71. PubMed ID: 16186281 [TBL] [Abstract][Full Text] [Related]
11. Correlation Between Vitreous Advanced Glycation End Products, and D-dimer with Blood HbA1c Levels in Proliferative Diabetic Retinopathy. Loho T; Venna V; Setiabudy RD; Sukartini N; Immanuel S; Kumalawati J; Victor AA; Waspadji S Acta Med Indones; 2018 Apr; 50(2):132-137. PubMed ID: 29950532 [TBL] [Abstract][Full Text] [Related]
12. Diabetic retinopathy risk correlates with intracellular concentrations of the glycoxidation product Nepsilon-(carboxymethyl) lysine independently of glycohaemoglobin concentrations. Hammes HP; Brownlee M; Lin J; Schleicher E; Bretzel RG Diabetologia; 1999 May; 42(5):603-7. PubMed ID: 10333054 [TBL] [Abstract][Full Text] [Related]
13. Early Formation of Serum Advanced Glycation End-Products in Children with Type 1 Diabetes Mellitus: Relationship with Glycemic Control. Jaisson S; Souchon PF; Desmons A; Salmon AS; Delemer B; Gillery P J Pediatr; 2016 May; 172():56-62. PubMed ID: 26947567 [TBL] [Abstract][Full Text] [Related]
14. Validity of random blood glucose as a predictor of the quality of glycaemic control by glycated haemoglobin in out-patient diabetic patients at Kenyatta National Hospital. Otieno FC; Ng'ang'a L; Kariuki M East Afr Med J; 2002 Sep; 79(9):491-5. PubMed ID: 12625691 [TBL] [Abstract][Full Text] [Related]
15. Serum levels of non-carboxymethyllysine advanced glycation endproducts are correlated to severity of microvascular complications in patients with Type 1 diabetes. Miura J; Yamagishi Si; Uchigata Y; Takeuchi M; Yamamoto H; Makita Z; Iwamoto Y J Diabetes Complications; 2003; 17(1):16-21. PubMed ID: 12505751 [TBL] [Abstract][Full Text] [Related]
16. Advanced glycation end products in adolescents and young adults with diabetic angiopathy. Chiarelli F; Catino M; Tumini S; Cipollone F; Mezzetti A; Vanelli M; Verrotti A Pediatr Nephrol; 2000 Aug; 14(8-9):841-6. PubMed ID: 10955941 [TBL] [Abstract][Full Text] [Related]
17. N-(carboxymethyl)valine residues in hemoglobin (CMV-Hb) reflect accumulation of oxidative stress in diabetic patients. Shimada S; Tanaka Y; Ohmura C; Tamura Y; Shimizu T; Uchino H; Watada H; Hirose T; Nakaniwa T; Miwa S; Kawamori R Diabetes Res Clin Pract; 2005 Sep; 69(3):272-8. PubMed ID: 16098924 [TBL] [Abstract][Full Text] [Related]
18. Serum levels of glucose-derived advanced glycation end products are associated with the severity of diabetic retinopathy in type 2 diabetic patients without renal dysfunction. Koga K; Yamagishi S; Okamoto T; Inagaki Y; Amano S; Takeuchi M; Makita Z Int J Clin Pharmacol Res; 2002; 22(1):13-7. PubMed ID: 12395914 [TBL] [Abstract][Full Text] [Related]
19. Aldimine Formation Reaction, the First Step of the Maillard Early-phase Reaction, Might be Enhanced in Variant Hemoglobin, Hb Himeji. Koga M; Inada S; Shimizu S; Hatazaki M; Umayahara Y; Nishihara E Ann Clin Lab Sci; 2015; 45(6):643-9. PubMed ID: 26663794 [TBL] [Abstract][Full Text] [Related]
20. Values of markers of early and advanced glycation and lipoxidation in serum proteins of children with diabetes mellitus. Jakus V; Bauerova K; Michalkova D; Carsky J Bratisl Lek Listy; 2000; 101(9):484-9. PubMed ID: 11187050 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]